The M4 muscarinic receptor-selective effects on keratinocyte crawling locomotion

Life Sciences

Volumn 72, Issue 18-19, 2003, Pages 2069-2073

  Chernyavsky, Alex I ^a   Nguyen, Vu Thuong ^a   Arredondo, Juan ^a   Ndoye, Assane ^a   Zia, Shaheen ^a   Wess, Jürgen ^b   Grando, Sergei A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

Keratinocyte motility; Knockout mouse; M4 muscarinic receptor

Indexed keywords

ACETYLCHOLINE; ATROPINE; MUSCARINIC RECEPTOR; PIRENZEPINE; TROPICAMIDE; 4 DIPHENYLACETOXY 1,1 DIMETHYLPIPERIDINIUM; 4-DIPHENYLACETOXY-1,1-DIMETHYLPIPERIDINIUM; MUSCARINE; MUSCARINIC AGENT; MUSCARINIC M4 RECEPTOR; PIPERIDINE DERIVATIVE;

ARTICLE; CELL ASSAY; CELL FUNCTION; CELL MIGRATION; CELL MOTILITY; CELL POPULATION; CHOLINERGIC SYSTEM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOSE RESPONSE; EPIDERMIS CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; LOCOMOTION; MOLECULAR BIOLOGY; PROTEIN ANALYSIS; REGULATORY MECHANISM; WILD TYPE; ANIMAL; CELL MOTION; DRUG EFFECT; MOUSE; MOUSE MUTANT; NEWBORN; PHYSIOLOGY; STIMULATION;

MURINAE;

ANIMALS; ATROPINE; CELL MOVEMENT; HUMANS; INFANT, NEWBORN; KERATINOCYTES; MICE; MICE, KNOCKOUT; MUSCARINE; MUSCARINIC AGONISTS; PIPERIDINES; PIRENZEPINE; RECEPTOR, MUSCARINIC M4; RECEPTORS, MUSCARINIC; STIMULATION, CHEMICAL;

EID: 0037470607     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00085-7     Document Type: Article

References (12)

1. Donaldson D.J., Mahan J.T. Keratinocyte migration and the extracellular matrix. Journal of Investigative Dermatology. 90:1988;623-628.
2. Woodley D.T. Reepithelialization. Clark R.A.F. The Molecular and Cellular Biology of Wound Repair. 2nd ed. 1996;339-354 Plenum Press, New York.
3. Klapproth H., Reinheimer T., Metzen J., Munch M., Bittinger F., Kirkpatrick C.J., Hohle K.D., Schemann M., Racke K., Wessler I. Non-neuronal acetylcholine, a signalling molecule synthesized by surface cells of rat and man. Naunyn-Schmiedeberg's Archives of Pharmacology. 355:1997;515-523.
4. Grando S.A. Biological functions of keratinocyte cholinergic receptors. Journal of Investigative Dermatology Symposium Proceeding. 2:1997;41-48.
5. Wess J, Duttaroy A, Miyakawa T, Zhang W, Gomeza J, Cui Y, Bymaster FP, McKinzie DL, Felder CC, Lamping KG, Faraci FM, Deng C, Yamada M. M1-M5 Muscarinic receptor knockout mice as novel tools to study the physiological roles of the muscarinic cholinergic system. Receptors and Channels [in press].
6. Gomeza J., Zhang L., Kostenis E., Felder C., Bymaster F., Brodkin J., Shannon H., Xia B., Deng C.-X., Wess J. Enhancement of D1 dopamine receptor-mediated locomotor stimulation in M4 muscarinic acetylcholine receptor knockout mice. Proceedings of the National Academy of Sciences of the United States of America. 96:1999;10483-10488.
7. Grando S.A., Crosby A.M., Zelickson B.D., Dahl M.V. Agarose gel keratinocyte outgrowth system as a model of skin re-epithelization: requirement of endogenous acetylcholine for outgrowth initiation. Journal of Investigative Dermatology. 101:1993;804-810.
8. 35S]-GTP gamma S binding mediated by human muscarinic m1-m4 receptors: antagonist studies. British Journal of Pharmacology. 109:1993;1120-1127.
9. Kebabian J.W., Neumeyer J.L. The RBI Handbook of Receptor Classification. 1994;Research Biochemicals International, Natick.
10. Zheng J.Q., Felder M., Poo M.M. Turning of nerve growth cones induced by neurotransmitters. Nature. 368:1994;140-144.
11. Buckley N.J., Bonner T.I., Buckley C.M., Brann M.R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Molecular Pharmacology. 35:1989;469-476.
12. McCawley L.J., Li S., Benavidez M., Halbleib J., Wattenberg E.V., Hudson L.G. Elevation of intracellular cAMP inhibits growth factor-mediated matrix metalloproteinase-9 induction and keratinocyte migration. Molecular Pharmacology. 58:2000;145-151.